Search results for Food and Drug Administration
Industry
Nearly half of U.S. obesity drug users did not follow prescription rules, survey finds
About 1 in 10 U.S. adults used GLP-1 drugs for obesity or diabetes treatment, a survey by the U.S. Centers for Disease Control and Prevention found. Among 976 users, 44 percent said they used the drugs differently from prescriptions, most commonly skipping doses. Users cited cost and supply problems as reasons. Use of compounded GLP-1 drugs was also reported, and those users were more likely to deviate from prescriptions.
Industry
Retatrutide shows knee osteoarthritis pain relief in trials
Eli Lilly’s next-generation obesity treatment retatrutide showed effectiveness in weight loss and easing knee osteoarthritis pain in large clinical trials. In two phase 3 studies published in The New England Journal of Medicine, weekly injections produced greater weight reduction and improved pain scores than placebo in overweight or obese adults without type 2 diabetes who also had knee osteoarthritis. Serious adverse events were more frequent than with placebo, with common side effects including nausea and diarrhoea.
Industry
U.S. military to spend $73 million to develop room-temperature artificial blood, aims for 2029 deployment
The U.S. Defense Advanced Research Projects Agency has launched a programme to develop blood substitutes that can be stored for long periods at room temperature, aiming to ease shortages on the battlefield. The $73 million RAPIID effort seeks longer-lasting plasma, platelets and red blood cell substitutes and targets field deployment in 2029. Candidate technologies will be tested in parallel, moving from large-animal work to human trials under University of Colorado Anschutz oversight.
-
Industry
Samsung Galaxy Watch expands from personal health management to family monitoring tool
-
Telecommunications & Media
Apple Watch Series 12 may debut next week with new chip, health upgrades and ceramic option
-
AI & Enterprise
AI trained on discarded human skin after surgery finds new cosmetic ingredients, bio startup says
-
Telecommunications & Media
Apple Watch Ultra 4, Series 12 set for September debut with internal upgrades
-
Telecommunications & Media
Apple Watch Ultra 4: Three key changes in focus ahead of release
-
Industry
Johnson & Johnson\'s Ottava surgical robot wins U.S. FDA approval
-
Industry
U.S. biotech Axiom chooses Hong Kong over Nasdaq for first listing
-
Telecommunications & Media
Apple Watch Series 12 may drop Touch ID, focus on health features and battery
-
Industry
Seoul Hongneung, Pohang, Incheon Seo-gu and Jinju small strong special zones rated excellent
-
AI & Enterprise
Midjourney develops 60-second full-body ultrasound scanner, claims 100 times faster than MRI
-
Telecommunications & Media
watchOS 27 to be unveiled next week, three Apple Watch changes to watch
-
Finance
JPMorgan CEO warns Claude Mythos poses high cyber risk, finance must prepare
-
Telecommunications & Media
Samsung Electronics rolls out Galaxy Watch blood pressure tracking in U.S.
-
Games & Commerce
Naver D2SF makes follow-on investment in North America-focused healthcare startups Soundable Health and Nubilab
-
Industry
Physical AI spreads into medical and sensing fields as global companies eye Korea